CD8A and neoplasm: At the 5 years’ benchmark, the worse prognosis of OSE-like tumors remains however unaffected by the extent of CD8+ infiltrate, pointing to the possibility that active immunosuppression could eventually set in and contribute to the worse outcome of this specific tumor type.